Current Opinion in Virology

Papers
(The TQCC of Current Opinion in Virology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Structure of SARS-CoV-2 spike protein127
Developing a direct acting, orally available antiviral agent in a pandemic: the evolution of molnupiravir as a potential treatment for COVID-19121
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection99
Recent advances in antiviral drug development towards dengue virus74
Future considerations for the mRNA-lipid nanoparticle vaccine platform64
Current challenges to virus discovery by meta-transcriptomics60
Zoonotic disease and virome diversity in bats59
Global overview and major challenges of host prediction methods for uncultivated phages57
Structure and function of SARS-CoV-2 polymerase53
Coronavirus entry: how we arrived at SARS-CoV-253
Animal models for SARS-CoV-252
The virome of vector mosquitoes51
Dengue vaccine development by the year 2020: challenges and prospects49
The healthy human virome: from virus–host symbiosis to disease48
A new generation of vaccines based on alphavirus self-amplifying RNA48
A structural view of the SARS-CoV-2 virus and its assembly47
RNA viruses and the cGAS-STING pathway: reframing our understanding of innate immune sensing46
An update on salicylic acid biosynthesis, its induction and potential exploitation by plant viruses44
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus42
Cell-to-cell movement of plant viruses via plasmodesmata: a current perspective on potyviruses42
Recent advances in understanding plant antiviral RNAi and viral suppressors of RNAi41
Engineering therapeutic phages for enhanced antibacterial efficacy40
COVID-19, the first pandemic in the post-genomic era39
Structure, function and assembly of the long, flexible tail of siphophages39
Viral Z-RNA triggers ZBP1-dependent cell death37
Salicylic acid: transport and long-distance immune signaling36
European regulatory aspects of phage therapy: magistral phage preparations35
Host cell-intrinsic innate immune recognition of SARS-CoV-235
Interfering with SARS-CoV-2: are interferons friends or foes in COVID-19?34
Dengue mouse models for evaluating pathogenesis and countermeasures34
Anti-viral protective capacity of tissue resident memory T cells34
Risk factors and biomarkers of severe dengue33
Perspective on taxonomic classification of uncultivated viruses33
Tombusviruses orchestrate the host endomembrane system to create elaborate membranous replication organelles31
Influenza D virus31
Mitigation of evolved bacterial resistance to phage therapy31
Detection of viruses by inflammasomes30
Entry of influenza A virus into host cells — recent progress and remaining challenges29
Adenovirus – a blueprint for gene delivery28
Viral structural proteins as targets for antivirals28
Current view and perspectives in viroid replication28
Rotavirus cell entry: not so simple after all27
Drug resistance mutations in HIV: new bioinformatics approaches and challenges27
Natural killer cells and unconventional T cells in COVID-1926
Epigenetic control of the Epstein-Barr lifecycle26
Extracellular vesicles in virus infection and pathogenesis25
Progress and pitfalls of a year of drug repurposing screens against COVID-1925
Hepatitis B virus–host interactions and novel targets for viral cure25
Phage banks as potential tools to rapidly and cost-effectively manage antimicrobial resistance in the developing world25
Digital phagograms: predicting phage infectivity through a multilayer machine learning approach24
Immune system control of hepatitis C virus infection24
Cytomegalovirus as an immunomodulator across the lifespan24
Animal models of SARS-CoV-2 transmission24
Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy24
Critical view on RNA silencing-mediated virus resistance using exogenously applied RNA23
R gene mediated defense against viruses22
Development of plant-made monoclonal antibodies against viral infections22
Proteases and variants: context matters for SARS-CoV-2 entry assays22
Mapping the diverse structural landscape of the flavivirus antibody repertoire22
Nucleic acid-mediated PAMP-triggered immunity in plants22
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV00521
Tissues: the unexplored frontier of antibody mediated immunity21
The gut virome in inflammatory bowel diseases21
Molecular dynamics of the viral life cycle: progress and prospects21
The long and winding road: human papillomavirus entry and subcellular trafficking21
An overview of the current state of phage therapy for the treatment of biofilm-related infections21
Principles of epithelial homeostasis control during persistent human papillomavirus infection and its deregulation at the cervical transformation zone21
Phage therapy for secondary bacterial infections with COVID-1920
Assembly of the virome in newborn human infants20
Targeting of viral RNAs by Upf1-mediated RNA decay pathways20
UPR signaling at the nexus of plant viral, bacterial, and fungal defenses20
Remdesivir for the treatment of Covid-19: the value of biochemical studies19
Revisiting an old friend: new findings in alphavirus structure and assembly19
Evolution of the interferon response: lessons from ISGs of diverse mammals18
Rhabdoviruses as vectors for vaccines and therapeutics18
Broadly neutralizing antibodies against HIV-1 and concepts for application18
Human genetic and immunological dissection of papillomavirus-driven diseases: new insights into their pathogenesis18
Antiviral immunity triggered by infection-induced host transposable elements18
Measles immunity and immunosuppression18
Unresolved questions in the zoonotic transmission of MERS18
0.026167869567871